Health Care: Drugs

Cleveland BioLabs Inc (CBLI: NASDAQ)

$2.63 -0.15 | -5.4%
07/21/17 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.78
52 Week High 5.55
52 Week Low 1.22
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) -1.16
Share Related Items
Mkt Cap (Mil) 31.36
Shares Out (Mil) 11.28
Float (Mil) 4.41
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.20
Current Ratio 5.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.56
Price/Book 5.29
Price/Cash Flow -8.80
Per Share Data
Earnings -0.33
Sales 0.29
Book Value 0.53
Cash Flow -0.32
Business Summary
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
General Information
73 High Street
Buffalo, NY 14203
Industry : Drugs
Sector: Health Care
Employees: 15
CEO: Dr. Yakov Kogan,PhD
Short Interest
Current Month (Mil) 0.11
Previous Month (Mil) 0.13
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -26.10
Return on Investments -61.10
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CBLI

Latest CBLI Headlines from TheStreet

More Financial News for CBLI

Press Releases for CBLI

See All Press Releases

Partner Headlines for CBLI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter